ArticleJournal of the National Cancer Institute2008

Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.

Ji Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.